ALPMY Recent News Medivation Swings to Earnings i

ALPMY Recent News

Medivation Swings to Earnings in Q4 - Analyst Blog Zacks Investment Research - Fri Feb 28, 8:30AM CST
Biotech Stock Roundup: Regeneron's Eylea Impresses, Gilead Files for Next HCV Drug - Analyst Blog Zacks Investment Research - Wed Feb 19, 8:27AM CST
Primco Files Preliminary Form 14c to Increase Authorized Shares PR Newswire - Tue Feb 18, 11:30PM CST
AVEO/Astellas Terminate Agreement - Analyst Blog Zacks Investment Research - Tue Feb 18, 3:30PM CST
Vical Q4 Loss Narrows - Analyst Blog Zacks Investment Research - Thu Feb 13, 11:10AM CST
Announcement of Intention to Privatize and Invitation to Express Interest PR Newswire - Thu Feb 13, 4:31AM CST
Cytokinetics Rises on Q4 Earnings Beat - Analyst Blog Zacks Investment Research - Mon Feb 10, 10:00AM CST
AVEO/Astellas Terminate Tivozanib Trial - Analyst Blog Zacks Investment Research - Fri Jan 31, 4:10PM CST
Medivation Prevails in PREVAIL Study - Analyst Blog Zacks Investment Research - Wed Jan 29, 12:50PM CST
Early 2014 Advancing Companies with Expansion & New Distribution Opportunities: RiceBran, Whole Foods, Hain Celestial, DryShips and Chelsea Therapeutics PR Newswire - Thu Jan 16, 8:05AM CST